Rating History for Arrowhead Pharma (ARWR) by JPMorgan
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/1/2026 | Brian Cheng | New Coverage | Overweight (N/A) |
88.00 (N/A) |
70.53 (82.00) |
16.26% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/1/2026 | Brian Cheng | New Coverage | Overweight (N/A) |
88.00 (N/A) |
70.53 (82.00) |
16.26% | Details |